Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 46-54

  Long, Qi ^a   Johnson, Brent A ^a   Osunkoya, Adeboye O ^a,b,c   Lai, Yu Heng ^a,b   Zhou, Wei ^a,b   Abramovitz, Mark ^d   Xia, Mingjing ^a   Bouzyk, Mark B ^a,b   Nam, Robert K ^e,f   Sugar, Linda ^e,f   Stanimirovic, Aleksandra ^e,f   Williams, Daron J ^b   Leyland Jones, Brian R ^a,b   Seth, Arun K ^e,f   Petros, John A ^a,b,c   Moreno, Carlos S ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d Virginia Mason Institute of Research   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN G2; DASL PROTEIN; FORMALDEHYDE; FRUCTOSE 1,6 BISPHOSPHATASE 1; LETM1 DOMAIN CONTAINING 1 PROTEIN; LIPOCORTIN 1; LYMPHOCYTE ANTIGEN; MICRORNA; MICRORNA 519D; MICRORNA 647; NOTCH HOMOLOG 3 PROTEIN; NOTCH3 RECEPTOR; PARAFFIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN BID; RAD23 HOMOLOG B PROTEIN; RNA; SINGLE MINDED HOMOLOG 2 PROTEIN; TRANSCRIPTION FACTOR ER81; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; EMBEDDING; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC IDENTIFICATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RNA ISOLATION; TISSUE FIXATION; TREATMENT OUTCOME; VALIDATION PROCESS;

CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 80052453850     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.008     Document Type: Article

References (57)

1. American Cancer Society Cancer Facts & Figures 2009 2009 American Cancer Society Atlanta
2. M. Bibikova, D. Talantov, E. Chudin, J.M. Yeakley, J. Chen, D. Doucet, E. Wickham, D. Atkins, D. Barker, M. Chee, Y. Wang, and J.B. Fan Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays Am J Pathol 165 2004 1799 1807
3. J.B. Fan, J.M. Yeakley, M. Bibikova, E. Chudin, E. Wickham, J. Chen, D. Doucet, P. Rigault, B. Zhang, R. Shen, C. McBride, H.R. Li, X.D. Fu, A. Oliphant, D.L. Barker, and M.S. Chee A versatile assay for high-throughput gene expression profiling on universal array matrices Genome Res 14 2004 878 885
4. M. Abramovitz, M. Ordanic-Kodani, Y. Wang, Z. Li, C. Catzavelos, M. Bouzyk, G.W. Sledge Jr., C.S. Moreno, and B. Leyland-Jones Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay Biotechniques 44 2008 417 423
5. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826
6. S. Varambally, J. Yu, B. Laxman, D.R. Rhodes, R. Mehra, S.A. Tomlins, R.B. Shah, U. Chandran, F.A. Monzon, M.J. Becich, J.T. Wei, K.J. Pienta, D. Ghosh, M.A. Rubin, and A.M. Chinnaiyan Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Cancer Cell 8 2005 393 406
7. J. Lapointe, C. Li, J.P. Higgins, M. Van De Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. DeMarzo, R. Tibshirani, D. Botstein, P.O. Brown, J.D. Brooks, and J.R. Pollack Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811 816
8. E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, and W.L. Gerald Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res 62 2002 4499 4506
9. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J.E. Montie, R.B. Shah, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
10. P. Liu, S. Ramachandran, M. Ali-Seyed, C.D. Scharer, N. Laycock, W.B. Dalton, H. Williams, S. Karanam, M.W. Datta, D. Jaye, and C.S. Moreno Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells Cancer Res 46 2006 4011 4019
11. M. Bibikova, E. Chudin, A. Arsanjani, L. Zhou, E.W. Garcia, J. Modder, M. Kostelec, D. Barker, T. Downs, J.B. Fan, and J. Wang-Rodriguez Expression signatures that correlated with Gleason score and relapse in prostate cancer Genomics 89 2007 666 672
12. L. True, I. Coleman, S. Hawley, C.Y. Huang, D. Gifford, R. Coleman, T.M. Beer, E. Gelmann, M. Datta, E. Mostaghel, B. Knudsen, P. Lange, R. Vessella, D. Lin, L. Hood, and P.S. Nelson A molecular correlate to the Gleason grading system for prostate adenocarcinoma Proc Natl Acad Sci U S A 103 2006 10991 10996
13. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
14. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, and J.H. Luo Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790 2799
15. S.A. Tomlins, B. Laxman, S.M. Dhanasekaran, B.E. Helgeson, X. Cao, D.S. Morris, A. Menon, X. Jing, Q. Cao, B. Han, J. Yu, L. Wang, J.E. Montie, M.A. Rubin, K.J. Pienta, D. Roulston, R.B. Shah, S. Varambally, R. Mehra, and A.M. Chinnaiyan Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer Nature 448 2007 595 599
16. S.A. Tomlins, R. Mehra, D.R. Rhodes, L.R. Smith, D. Roulston, B.E. Helgeson, X. Cao, J.T. Wei, M.A. Rubin, R.B. Shah, and A.M. Chinnaiyan TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Res 66 2006 3396 3400
17. R. Tibshirani The lasso method for variable selection in the Cox model Stat Med 16 1997 385 395
18. J.J. Goeman L1 penalized estimation in the Cox proportional hazards model Biom J 52 2010 70 84
19. R.J.A. Little, and D.B. Rubin Statistical Analysis with Missing Data New York, Wiley 2002
20. B.S. Thoma, and K.M. Vasquez Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair Mol Carcinog 38 2003 1 13
21. C. Brignone, K.E. Bradley, A.F. Kisselev, and S.R. Grossman A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway Oncogene 23 2004 4121 4129
22. A.J. Yanez, F. Nualart, C. Droppelmann, R. Bertinat, M. Brito, I.I. Concha, and J.C. Slebe Broad expression of fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney J Cell Physiol 197 2003 189 197
23. H. Hsu, J. Xiong, and D.V. Goeddel The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation Cell 81 1995 495 504
24. A. Thorburn Death receptor-induced cell killing Cell Signal 16 2004 139 144
25. Z. Wang, Y. Li, A. Ahmad, S. Banerjee, A.S. Azmi, D. Kong, C. Wojewoda, L. Miele, and F.H. Sarkar Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells J Cell Biochem 112 2011 78 88
26. Z. Wang, Y. Li, S. Banerjee, D. Kong, A. Ahmad, V. Nogueira, N. Hay, and F.H. Sarkar Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways J Cell Biochem 109 2010 726 736
27. G. Kulik, J.P. Carson, T. Vomastek, K. Overman, B.D. Gooch, S. Srinivasula, E. Alnemri, G. Nunez, and M.J. Weber Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells Cancer Res 61 2001 2713 2719
28. X. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 1998 481 490
29. M.P. Deyoung, D. Scheurle, H. Damania, C. Zylberberg, and R. Narayanan Down's syndrome-associated single minded gene as a novel tumor marker Anticancer Res 22 2002 3149 3157
30. O.J. Halvorsen, K. Rostad, A.M. Oyan, H. Puntervoll, T.H. Bo, L. Stordrange, S. Olsen, S.A. Haukaas, L. Hood, I. Jonassen, K.H. Kalland, and L.A. Akslen Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer Clin Cancer Res 13 2007 892 897
31. M.S. Arredouani, B. Lu, M. Bhasin, M. Eljanne, W. Yue, J.M. Mosquera, G.J. Bubley, V. Li, M.A. Rubin, T.A. Libermann, and M.G. Sanda Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer Clin Cancer Res 15 2009 5794 5802
32. M.P. DeYoung, M. Tress, and R. Narayanan Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors Proc Natl Acad Sci U S A 100 2003 4760 4765
33. C.P. Paweletz, D.K. Ornstein, M.J. Roth, V.E. Bichsel, J.W. Gillespie, V.S. Calvert, C.D. Vocke, S.M. Hewitt, P.H. Duray, J. Herring, Q.H. Wang, N. Hu, W.M. Linehan, P.R. Taylor, L.A. Liotta, M.R. Emmert-Buck, and E.F. Petricoin 3rd Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma Cancer Res 60 2000 6293 6297
34. K.T. Patton, H.M. Chen, L. Joseph, and X.J. Yang Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia Histopathology 47 2005 597 601
35. S. Maschler, C.A. Gebeshuber, E.M. Wiedemann, M. Alacakaptan, M. Schreiber, I. Custic, and H. Beug Annexin A1 attenuates EMT and metastatic potential in breast cancer EMBO Mol Med 2 2010 401 414
36. J. Inokuchi, A. Lau, D.R. Tyson, and D.K. Ornstein Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling Carcinogenesis 30 2009 1082 1088
37. E.S. Alnemri, N.M. Robertson, T.F. Fernandes, C.M. Croce, and G. Litwack Overexpressed full-length human BCL2 extends the survival of baculovirus- infected Sf9 insect cells Proc Natl Acad Sci U S A 89 1992 7295 7299
38. A.J. Wagner, M.B. Small, and N. Hay Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 Mol Cell Biol 13 1993 2432 2440
39. S. Bates, S. Rowan, and K.H. Vousden Characterisation of human cyclin G1 and G2: dNA damage inducible genes Oncogene 13 1996 1103 1109
40. L. Martinez-Gac, M. Marques, Z. Garcia, M.R. Campanero, and A.C. Carrera Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead Mol Cell Biol 24 2004 2181 2189
41. A.S. Arachchige Don, R.F. Dallapiazza, D.A. Bennin, T. Brake, C.E. Cowan, and M.C. Horne Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest Exp Cell Res 312 2006 4181 4204
42. G.W. Cho, M.H. Kim, S.H. Kim, S.A. Ha, H.K. Kim, S. Kim, and J.W. Kim TCF/ beta-catenin plays an important role in HCCR-1 oncogene expression BMC Mol Biol 10 2009 42
43. G.W. Cho, S.M. Shin, H. Namkoong, H.K. Kim, S.A. Ha, S.Y. Hur, T.E. Kim, Y.G. Chai, and J.W. Kim The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression Gene 384 2006 18 26
44. J. Ko, Y.H. Lee, S.Y. Hwang, Y.S. Lee, S.M. Shin, J.H. Hwang, J. Kim, Y.W. Kim, S.W. Jang, Z.Y. Ryoo, I.K. Kim, S.E. Namkoong, and J.W. Kim Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization Oncogene 22 2003 4679 4689
45. S.S. Jung, H.S. Park, I.J. Lee, H. Namkoong, S.M. Shin, G.W. Cho, S.A. Ha, Y.G. Park, Y.S. Lee, J. Ko, and J.W. Kim The HCCR oncoprotein as a biomarker for human breast cancer Clin Cancer Res 11 2005 7700 7708
46. R. Martinelli, C. Nardelli, V. Pilone, T. Buonomo, R. Liguori, I. Castano, P. Buono, S. Masone, G. Persico, P. Forestieri, L. Pastore, and L. Sacchetti miR-519d overexpression is associated with human obesity Obesity (Silver Spring) 18 2010 2170 2176
47. J. Fan, and J. Lv Sure independence screening for ultrahigh dimensional feature space J R Stat Soc Ser B Stat Methodol 70 2008 849 911
48. J. Fan, and R. Song Sure independence screening in generalized linear models and NP-dimensionality Ann Stat 38 2010 3567 3604
49. S.D. Zhao, and Y. Li Principled sure independence screening for Cox models with ultra-high-dimensional covariates Harvard University Biostatistics Working Paper Series 2010 2010 Harvard University Department of Biostatistics Boston
50. A. Sboner, F. Demichelis, S. Calza, Y. Pawitan, S.R. Setlur, Y. Hoshida, S. Perner, H.O. Adami, K. Fall, L.A. Mucci, P.W. Kantoff, M. Stampfer, S.O. Andersson, E. Varenhorst, J.E. Johansson, M.B. Gerstein, T.R. Golub, M.A. Rubin, and O. Andren Molecular sampling of prostate cancer: a dilemma for predicting disease progression BMC Med Genomics 3 2010 8
51. T. Nakagawa, T.M. Kollmeyer, B.W. Morlan, S.K. Anderson, E.J. Bergstralh, B.J. Davis, Y.W. Asmann, G.G. Klee, K.V. Ballman, and R.B. Jenkins A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy PLoS ONE 3 2008 e2318
52. K.G. Leong, and W.Q. Gao The Notch pathway in prostate development and cancer Differentiation 76 2008 699 716
53. X.D. Wang, C.C. Leow, J. Zha, Z. Tang, Z. Modrusan, F. Radtke, M. Aguet, F.J. de Sauvage, and W.Q. Gao Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation Dev Biol 290 2006 66 80
54. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz Jr., J. Hartigan, D.R. Smith, R.L. Strausberg, S.K. Marie, S.M. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
55. J.C. Cheville, R.J. Karnes, T.M. Therneau, F. Kosari, J.M. Munz, L. Tillmans, E. Basal, L.J. Rangel, E. Bergstralh, I.V. Kovtun, C.D. Savci-Heijink, E.W. Klee, and G. Vasmatzis Gene panel model predictive of outcome in men at highrisk of systemic progression and death from prostate cancer after radical retropubic prostatectomy J Clin Oncol 26 2008 3930 3936
56. A.L. Farrall, and M.L. Whitelaw The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element Oncogene 28 2009 3671 3680
57. S.K. Yoon, N.K. Lim, S.A. Ha, Y.G. Park, J.Y. Choi, K.W. Chung, H.S. Sun, M.J. Choi, J. Chung, J.R. Wands, and J.W. Kim The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma Cancer Res 64 2004 5434 5441